Method of treating cancer using a neuropeptide Y 5R (NP Y5R) antagonist

Details for Australian Patent Application No. 2009225189 (hide)

Owner University Health Network

Inventors Pan, Guohua

Agent Davies Collison Cave

Pub. Number AU-B-2009225189

PCT Pub. Number WO2009/111868

Priority 61/068,900 11.03.08 US; 61/190,356 28.08.08 US; 61/126,909 08.05.08 US; 61/118,231 26.11.08 US

Filing date 10 March 2009

Wipo publication date 17 September 2009

Acceptance publication date 2 August 2012

International Classifications

A61K 31/4355

A61K 31/513 - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 Antineoplastic agents

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111868 Priority application(s): WO2009/111868

2 August 2012 Application Accepted

  Published as AU-B-2009225189

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225235-A barbeque hood and an associated lighting arrangement

2009225171-The compounds as the estrogen related receptors modulators and the uses thereof